OpenBilldrug price receipt

NADAC week of 2026-10-14

FUROSEMIDE 20 MG TABLET

For 30 tablets

Pharmacies pay

$0.78 filed

30 × $0.02602 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$5.90 estimated

$0.78 + $0.12 (15%) + $5.00 fee per fill = $5.90

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FUROSEMIDE 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as furosemide.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Major Pharmaceuticals and Solco Healthcare LLC.

FDA’s Established Pharmacologic Class for it is Loop Diuretic.

The NADAC file of 2026-10-14 prices it under 16 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.78 for 30 tablets (30 × $0.02602 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 9 labelers

LabelerNDCsPharmacies pay per unit
Hikma Pharmaceuticals USA Inc.3$0.02602 per EA filed
Aurobindo Pharma Limited2$0.02602 per EA filed
Ipca Laboratories Limited2$0.02602 per EA filed
Leading Pharma, LLC2$0.02602 per EA filed
Rising Pharma Holdings, Inc.2$0.02602 per EA filed
Solco Healthcare LLC2$0.02602 per EA filed
Chartwell RX, LLC1$0.02602 per EA filed
Granulation Technology, Inc.1$0.02602 per EA filed
Major Pharmaceuticals1$0.02602 per EA filed

When these prices took effect

All 16 NDCs, with labeler and price
  • 00054-4297-25 · Hikma Pharmaceuticals USA Inc. · $0.02602 per EA · eff. 2026-09-23 filed
  • 00054-4297-31 · Hikma Pharmaceuticals USA Inc. · $0.02602 per EA · eff. 2026-09-23 filed
  • 00054-8297-25 · Hikma Pharmaceuticals USA Inc. · $0.02602 per EA · eff. 2026-09-23 filed
  • 00904-7177-61 · Major Pharmaceuticals · $0.02602 per EA · eff. 2026-09-23 filed
  • 43547-0401-10 · Solco Healthcare LLC · $0.02602 per EA · eff. 2026-09-23 filed
  • 43547-0401-11 · Solco Healthcare LLC · $0.02602 per EA · eff. 2026-09-23 filed
  • 59651-0796-01 · Aurobindo Pharma Limited · $0.02602 per EA · eff. 2026-09-23 filed
  • 59651-0796-99 · Aurobindo Pharma Limited · $0.02602 per EA · eff. 2026-09-23 filed
  • 62135-0753-90 · Chartwell RX, LLC · $0.02602 per EA · eff. 2026-09-23 filed
  • 63561-0164-02 · Granulation Technology, Inc. · $0.02602 per EA · eff. 2026-09-30 filed
  • 64980-0562-01 · Rising Pharma Holdings, Inc. · $0.02602 per EA · eff. 2026-09-23 filed
  • 64980-0562-10 · Rising Pharma Holdings, Inc. · $0.02602 per EA · eff. 2026-09-23 filed
  • 69315-0116-01 · Leading Pharma, LLC · $0.02602 per EA · eff. 2026-09-23 filed
  • 69315-0116-10 · Leading Pharma, LLC · $0.02602 per EA · eff. 2026-09-23 filed
  • 83980-0002-01 · Ipca Laboratories Limited · $0.02602 per EA · eff. 2026-09-23 filed
  • 83980-0002-10 · Ipca Laboratories Limited · $0.02602 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name furosemide with FUROSEMIDE 20 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
FUROSEMIDE 1,000 MG/100 ML VL
generic · injection
$0.25253 per ML filed
eff. 2026-09-23
$0.18 per ML derived
Part B limit 2026 Q4
FUROSEMIDE 10 MG/ML SOLUTION
generic · solution
$0.09203 per ML filed
eff. 2026-09-23
We don’t know yet
FUROSEMIDE 20 MG TABLET this page
generic · tablet
$0.02602 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
FUROSEMIDE 20 MG/2 ML VIAL
generic · injection / injection, solution
$0.49014 per ML filed
eff. 2026-09-23
$0.18 per ML derived
Part B limit 2026 Q4
FUROSEMIDE 40 MG TABLET
generic · tablet
$0.0291 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
FUROSEMIDE 40 MG/4 ML ORAL SOLUTION CUP
generic · solution
$0.09203 per ML filed
eff. 2026-09-23
We don’t know yet
FUROSEMIDE 40 MG/4 ML VIAL
generic · injection, solution
$0.25253 per ML filed
eff. 2026-09-23
$0.18 per ML derived
Part B limit 2026 Q4
FUROSEMIDE 80 MG TABLET
generic · tablet
$0.04982 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
FUROSEMIDE 100 MG/10 ML VIAL
generic · injection
$0.25253 per ML filed
eff. 2026-09-23
$0.18 per ML derived
Part B limit 2026 Q4
FUROSEMIDE 500 MG/50 ML VIAL
generic · injection
$0.49014 per ML filed
eff. 2026-09-23
$0.18 per ML derived
Part B limit 2026 Q4
LASIX 20 MG TABLET
brand · tablet
$0.74852 per EA filed
eff. 2026-09-23
$0.93675 per EA filed
Part D 2024 average
LASIX 40 MG TABLET
brand · tablet
$1.0493 per EA filed
eff. 2026-09-23
$0.93675 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 16 NDCs’ NADAC prices is $0.02602 per EA filed.

Of the 12 other products in FDA’s Loop Diuretic class priced per EA, 12 have a higher middle NADAC price and 0 a lower one. The one in the middle is BUMETANIDE 1 MG TABLET, at $0.10789 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.